HLB bioStep Co.,Ltd. (KOSDAQ:278650)
6,360.00
-125.00 (-1.93%)
At close: Apr 23, 2026
HLB bioStep Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 107,645 | 122,820 | 176,390 | 242,875 | 327,966 | 219,226 | Upgrade
|
| Market Cap Growth | -28.21% | -30.37% | -27.37% | -25.95% | 49.60% | 14.63% | Upgrade
|
| Enterprise Value | 99,732 | 134,125 | 168,104 | 226,210 | 341,037 | 227,757 | Upgrade
|
| Last Close Price | 6360.00 | 7270.00 | 10475.00 | 15450.00 | 23250.00 | 15846.21 | Upgrade
|
| PE Ratio | - | - | - | - | - | 19.87 | Upgrade
|
| PS Ratio | 1.45 | 1.66 | 3.03 | 4.60 | 3.80 | 3.40 | Upgrade
|
| PB Ratio | 1.07 | 1.22 | 1.51 | 2.35 | 4.54 | 3.30 | Upgrade
|
| P/TBV Ratio | 1.17 | 1.34 | 1.73 | 2.43 | 4.79 | 3.50 | Upgrade
|
| P/FCF Ratio | 96.71 | 110.34 | - | 204.19 | 206.70 | - | Upgrade
|
| P/OCF Ratio | 34.88 | 39.80 | - | 46.78 | 50.61 | 25.90 | Upgrade
|
| EV/Sales Ratio | 1.35 | 1.81 | 2.89 | 4.28 | 3.95 | 3.54 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 98.80 | 36.23 | 18.93 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 64.24 | 25.29 | Upgrade
|
| EV/FCF Ratio | 89.60 | 120.50 | - | 190.18 | 214.94 | - | Upgrade
|
| Debt / Equity Ratio | 0.31 | 0.31 | 0.30 | 0.59 | 1.27 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 26.48 | 9.74 | 1.35 | Upgrade
|
| Debt / FCF Ratio | 27.64 | 27.64 | - | 50.98 | 57.76 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.12 | -0.12 | -0.10 | -0.09 | -0.07 | 0.09 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.22 | 3.22 | 1.46 | -4.25 | -0.58 | 0.49 | Upgrade
|
| Net Debt / FCF Ratio | -11.30 | -11.30 | 0.59 | -8.19 | -3.42 | -0.53 | Upgrade
|
| Asset Turnover | 0.46 | 0.46 | 0.34 | 0.31 | 0.65 | 0.76 | Upgrade
|
| Inventory Turnover | 12.09 | 12.09 | 11.33 | 10.96 | 14.15 | 8.80 | Upgrade
|
| Quick Ratio | 1.07 | 1.07 | 1.20 | 1.15 | 8.36 | 1.14 | Upgrade
|
| Current Ratio | 1.26 | 1.26 | 1.35 | 1.23 | 8.57 | 1.75 | Upgrade
|
| Return on Equity (ROE) | -18.60% | -18.60% | -8.80% | -0.06% | -1.27% | 19.00% | Upgrade
|
| Return on Assets (ROA) | -3.33% | -3.33% | -4.80% | -0.43% | 2.49% | 6.67% | Upgrade
|
| Return on Invested Capital (ROIC) | -8.32% | -8.95% | -13.15% | 0.25% | 7.64% | 13.51% | Upgrade
|
| Return on Capital Employed (ROCE) | -8.00% | -8.00% | -10.70% | -1.10% | 3.30% | 11.50% | Upgrade
|
| Earnings Yield | -17.61% | -15.44% | -4.86% | -0.07% | -0.31% | 5.03% | Upgrade
|
| FCF Yield | 1.03% | 0.91% | -11.68% | 0.49% | 0.48% | -5.08% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 10.26% | Upgrade
|
| Buyback Yield / Dilution | -0.82% | -0.82% | -9.45% | -9.59% | -0.02% | -1.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.